Mechanisms controlling the persistence of infectious HIV reservoirs in children

控制儿童感染性艾滋病毒储存库持续存在的机制

基本信息

  • 批准号:
    10224286
  • 负责人:
  • 金额:
    $ 56.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Twenty years ago effective treatments for HIV became available, and the lifespan of HIV-infected adults in high-resource settings has increased to within a decade of uninfected individuals. However, if therapy is stopped virus generally rebounds in the blood to pretreatment levels, due to viruses that persist and reactivate from the “HIV Reservoir”. Curative therapies suitable for the millions of infected individuals have been sought, including strategies using therapeutic vaccines, chemotherapies paired with stem-cell transplant, chimeric antigen receptor cells, gene therapies, cytokines and antiretroviral therapy during acute infection. While many of these have reduced the HIV reservoir and in one case may have cured HIV infection, a better understanding of the mechanisms that allow persistence of the reservoir are needed to develop an effective, safe and economical cure. The HIV reservoir of perinatally infected children are primarily established early in infection when their immune system is tolerogenic to foster a healthy gestation, postnatal colonization with commensal bacteria and tolerance of foods. We propose to examine four mechanisms that could contribute to sustaining the HIV reservoirs and compare the contribution of each in children versus adults. We hypothesize that two mechanisms will be specific to children: (1) immune tolerance of HIV, due to “perinatal” infection (in utero or the early weeks of life) when immune tolerance to non-self antigens including non-inherited maternal antigens (NIMA) and oral tolerance to foods are established; and (2) “cross immune tolerance” to HIV generated by increased levels of maternal microchimerism (MMc), as observed with allografts.15 In both adults and children, we hypothesize that the HIV reservoir is maintained by (3) modulation of gene expression by HIV integration in genes of Treg that promote survival of these cells, and/or through impairment of antiviral functions towards other infected cells; and (4) by the persistent loss of gut T-helper (Th)17 cells due to bacterial translocation eliciting pro-inflammatory cytokines that favor the development and persistence of Tregs instead of effective antiviral CD4+ T-cell help. Through studies of specimens collected prospectively from South African children known to have acquired HIV perinatally, their mothers and uninfected controls, we will measure parameters of each of these mechanisms to gain insight into the roles of these mechanisms in sustaining the infectious HIV reservoir. The knowledge gained regarding the relative contribution of these four mechanisms in children vs. adults should point to mechanisms most relevant to children that we could test in non-human primates (NHP), with the goal of developing interventions tailored to the unique mechanisms identified in children.
项目总结/摘要 20年前,艾滋病毒的有效治疗方法问世, 高资源环境已增加到未受感染者的十年内。如果治疗是 停止的病毒通常在血液中反弹到治疗前的水平,这是由于病毒持续存在并重新激活 从“艾滋病病毒库”已经寻求了适合于数百万受感染个体的治愈性疗法, 包括使用治疗性疫苗的策略,与干细胞移植配对的化疗,嵌合 急性感染期间的抗原受体细胞、基因疗法、细胞因子和抗逆转录病毒疗法。虽然许多 其中一些减少了艾滋病毒储存库,在一种情况下可能治愈了艾滋病毒感染, 的机制,使水库的持久性需要开发一个有效的,安全的, 经济治愈围产期感染儿童的HIV宿主主要在感染早期建立 当他们的免疫系统是耐受原性的,以促进健康的妊娠,出生后定植与寄生虫 细菌和食物的耐受性。我们建议审查四种机制, 艾滋病毒库,并比较儿童与成人中每种病毒的贡献。我们假设两个 机制将是特定于儿童:(1)免疫耐受的艾滋病毒,由于“围产期”感染(在子宫内或 当对非自身抗原包括非遗传的母体抗原的免疫耐受时 (2)对HIV产生的“交叉免疫耐受”, 母体微嵌合体(MMc)水平增加,如在同种异体移植物中观察到的。15在成人和儿童中, 我们假设HIV库是通过以下方式维持的:(3)HIV整合对基因表达的调节, Treg的基因,其促进这些细胞的存活,和/或通过损害针对其他细胞的抗病毒功能, 感染的细胞;和(4)由于细菌易位引起的肠道辅助性T细胞(Th)17细胞的持续丢失 促炎性细胞因子,有利于发展和持续的TcR,而不是有效的抗病毒 CD 4 + T细胞帮助。通过对从南非儿童身上收集的样本进行研究, 已获得艾滋病毒围产期,他们的母亲和未感染的控制,我们将测量参数的每一个 这些机制,以深入了解这些机制在维持感染性艾滋病毒水库的作用。 关于这四种机制在儿童与成人中的相对作用的知识 应该指出与儿童最相关的机制,我们可以在非人类灵长类动物(NHP)中进行测试, 制定针对儿童独特机制的干预措施的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lisa M Frenkel其他文献

The role of HIV biology in defining virological failure.
HIV 生物学在定义病毒学失败中的作用。
  • DOI:
    10.1016/s2352-3018(24)00033-x
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ceejay Boyce;Lisa M Frenkel
  • 通讯作者:
    Lisa M Frenkel
The In Vitro Growth and Serial Passage of RA 27/3 Rubella Vaccine Virus in Cord Blood Mononuclear Leukocytes from Normal Babies
  • DOI:
    10.1203/00006450-199505000-00011
  • 发表时间:
    1995-05-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Karin Nielsen;Alice Garakian;Lisa M Frenkel;James D Cherry
  • 通讯作者:
    James D Cherry

Lisa M Frenkel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lisa M Frenkel', 18)}}的其他基金

Mechanisms controlling the persistence of infectious HIV reservoirs in children
控制儿童感染性艾滋病毒储存库持续存在的机制
  • 批准号:
    9395284
  • 财政年份:
    2017
  • 资助金额:
    $ 56.42万
  • 项目类别:
Defining HIV reservoirs that rebound following suspension of ART
定义暂停 ART 后反弹的 HIV 病毒库
  • 批准号:
    10220678
  • 财政年份:
    2017
  • 资助金额:
    $ 56.42万
  • 项目类别:
Defining HIV reservoirs that rebound following suspension of ART
定义暂停 ART 后反弹的 HIV 病毒库
  • 批准号:
    9976441
  • 财政年份:
    2017
  • 资助金额:
    $ 56.42万
  • 项目类别:
A rapid point-of-treatment diagnostic assay for HIV-resistance to 1st-line ART
HIV 对第一线 ART 耐药性的快速治疗点诊断测定
  • 批准号:
    9266304
  • 财政年份:
    2014
  • 资助金额:
    $ 56.42万
  • 项目类别:
A rapid point-of-treatment diagnostic assay for HIV-resistance to 1st-line ART
HIV 对第一线 ART 耐药性的快速治疗点诊断测定
  • 批准号:
    9060867
  • 财政年份:
    2014
  • 资助金额:
    $ 56.42万
  • 项目类别:
Drug-resistance testing in Kenya to improve ART suppression of HIV replication
肯尼亚的耐药性检测可改善 ART 对 HIV 复制的抑制
  • 批准号:
    8298850
  • 财政年份:
    2012
  • 资助金额:
    $ 56.42万
  • 项目类别:
Drug-resistance testing in Kenya to improve ART suppression of HIV replication
肯尼亚的耐药性检测可改善 ART 对 HIV 复制的抑制
  • 批准号:
    8672592
  • 财政年份:
    2012
  • 资助金额:
    $ 56.42万
  • 项目类别:
Drug-resistance testing in Kenya to improve ART suppression of HIV replication
肯尼亚的耐药性检测可改善 ART 对 HIV 复制的抑制
  • 批准号:
    8488409
  • 财政年份:
    2012
  • 资助金额:
    $ 56.42万
  • 项目类别:
HIV-1 evolution in the female genital tract and trafficking to the blood
HIV-1 在女性生殖道中的进化和贩运到血液中
  • 批准号:
    8081383
  • 财政年份:
    2011
  • 资助金额:
    $ 56.42万
  • 项目类别:
HIV-1 evolution in the female genital tract and trafficking to the blood
HIV-1 在女性生殖道中的进化和贩运到血液中
  • 批准号:
    8602818
  • 财政年份:
    2011
  • 资助金额:
    $ 56.42万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 56.42万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 56.42万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 56.42万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 56.42万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 56.42万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 56.42万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 56.42万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 56.42万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 56.42万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 56.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了